Hana Securities Targets Celltrion at 310,000 Won

Cover art for Hana Securities Targets Celltrion at 310,000 Won

TL;DR: Hana Securities initiates Celltrion coverage with a 310,000 won target, citing U.S. biosimilar sales as growth driver. Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth. Hana Securities has initiated coverage on South Korea's Celltrion with a 'Buy' rating and a target price of 310,000 won.

BigGo FinanceNov 18, 2026

From · · · 1m 10s

TL;DR: Hana Securities Targets Celltrion at 310,000 Won

Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth.

Hana Securities initiates Celltrion coverage with a 310,000 won target, citing U.S. biosimilar sales as growth driver. Hana Securities boosts Celltrion stock with 310,000 won target, betting on U.S. biosimilar sales growth. Hana Securities has initiated coverage on South Korea's Celltrion with a 'Buy' rating and a target price of 310,000 won.

  • Hana Securities Initiates Coverage
  • Q3 Revenue and Profit Growth
  • U.S. Direct Sales Catalyst
  • Full-Year Projections

Read the story version — the same reporting as a swipeable deck of 7 cards.

Read the original on BigGo Finance

More news from the United States

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on hana securities and related topics.